Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Idiopathic Interstitial Pneumonias

NCT02230982: Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

No Longer Available

N/A

RoW

nintedanib

Boehringer Ingelheim

Idiopathic Pulmonary Fibrosis

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites